Dual pyroptotic biomarkers predict erythroid response in lower-risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin

Bibliographic Details
Main Authors:	Chen Wang, Kathy L. McGraw, Amy F. McLemore, Rami Komrokji, Ashley A. Basiorka, Najla Al Ali, Jeffrey E. Lancet, Eric Padron, Olivier Kosmider, Michaela Fontenay, Pierre Fenaux, Alan F. List, David A. Sallman
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2021-07-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/10348

Internet